Zavesca is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Miglustat.
Product ID | 66215-201_009942ad-7392-4bee-b722-663172bc7b60 |
NDC | 66215-201 |
Product Type | Human Prescription Drug |
Proprietary Name | Zavesca |
Generic Name | Miglustat |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2003-07-31 |
Marketing Category | NDA / NDA |
Application Number | NDA021348 |
Labeler Name | Actelion Pharmaceuticals US, Inc. |
Substance Name | MIGLUSTAT |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2003-07-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021348 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-03-16 |
Marketing Category | NDA |
Application Number | NDA021348 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-07-31 |
Marketing Category | NDA |
Application Number | NDA021348 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-07-31 |
Marketing End Date | 2016-03-16 |
Ingredient | Strength |
---|---|
MIGLUSTAT | 100 mg/1 |
SPL SET ID: | 817892d1-ee12-4632-85fc-57ccdf16d7b8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
66215-201 | Zavesca | miglustat |
10148-201 | Miglustat | miglustat |
42799-708 | Miglustat | Miglustat |
43975-310 | MIGLUSTAT | MIGLUSTAT |
51991-959 | miglustat | Miglustat |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZAVESCA 85185312 4089805 Live/Registered |
Actelion Pharmaceuticals Ltd. 2010-11-25 |
ZAVESCA 76082010 2641709 Live/Registered |
ACTELION PHARMACEUTICALS LTD. 2000-06-30 |